The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the ...

Researchers from the Wesfarmers Center of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

A new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation and ...

Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our infants with vaccination.

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization and mortality in children under six years old. With millions of cases annually worldwide, especially among infants under six ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...